452 related articles for article (PubMed ID: 16519520)
1. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
Arndt JW; Chai Q; Christian T; Stevens RC
Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of substrate recognition and specificity of botulinum neurotoxin serotype F.
Chen S; Wan HY
Biochem J; 2011 Jan; 433(2):277-84. PubMed ID: 21029044
[TBL] [Abstract][Full Text] [Related]
3. Botulinum neurotoxin serotype F: identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity.
Schmidt JJ; Stafford RG
Biochemistry; 2005 Mar; 44(10):4067-73. PubMed ID: 15751983
[TBL] [Abstract][Full Text] [Related]
4. Structural and biochemical characterization of the protease domain of the mosaic botulinum neurotoxin type HA.
Lam KH; Sikorra S; Weisemann J; Maatsch H; Perry K; Rummel A; Binz T; Jin R
Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29688327
[TBL] [Abstract][Full Text] [Related]
5. Development of a fusion protein SNVP as substrate for assaying multi-serotype botulinum neurotoxins.
Luo S; Li T; Wang Q; Tian R; Liu H; Fang H; Chen F; Wang H
Anal Biochem; 2014 Oct; 463():75-81. PubMed ID: 23851341
[TBL] [Abstract][Full Text] [Related]
6. Structural analysis of botulinum neurotoxin serotype F light chain: implications on substrate binding and inhibitor design.
Agarwal R; Binz T; Swaminathan S
Biochemistry; 2005 Sep; 44(35):11758-65. PubMed ID: 16128577
[TBL] [Abstract][Full Text] [Related]
7. Structural and biochemical studies of botulinum neurotoxin serotype C1 light chain protease: implications for dual substrate specificity.
Jin R; Sikorra S; Stegmann CM; Pich A; Binz T; Brunger AT
Biochemistry; 2007 Sep; 46(37):10685-93. PubMed ID: 17718519
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of botulinum neurotoxin type G light chain: serotype divergence in substrate recognition.
Arndt JW; Yu W; Bi F; Stevens RC
Biochemistry; 2005 Jul; 44(28):9574-80. PubMed ID: 16008342
[TBL] [Abstract][Full Text] [Related]
9. Rapid product analysis and increased sensitivity for quantitative determinations of botulinum neurotoxin proteolytic activity.
Rowe B; Schmidt JJ; Smith LA; Ahmed SA
Anal Biochem; 2010 Jan; 396(2):188-93. PubMed ID: 19782037
[TBL] [Abstract][Full Text] [Related]
10. Structure and activity of a functional derivative of Clostridium botulinum neurotoxin B.
Masuyer G; Beard M; Cadd VA; Chaddock JA; Acharya KR
J Struct Biol; 2011 Apr; 174(1):52-7. PubMed ID: 21078393
[TBL] [Abstract][Full Text] [Related]
11. Substrate recognition strategy for botulinum neurotoxin serotype A.
Breidenbach MA; Brunger AT
Nature; 2004 Dec; 432(7019):925-9. PubMed ID: 15592454
[TBL] [Abstract][Full Text] [Related]
12. Identification of the amino acid residues rendering TI-VAMP insensitive toward botulinum neurotoxin B.
Sikorra S; Henke T; Swaminathan S; Galli T; Binz T
J Mol Biol; 2006 Mar; 357(2):574-82. PubMed ID: 16430921
[TBL] [Abstract][Full Text] [Related]
13. Specificity of botulinum protease for human VAMP family proteins.
Yamamoto H; Ida T; Tsutsuki H; Mori M; Matsumoto T; Kohda T; Mukamoto M; Goshima N; Kozaki S; Ihara H
Microbiol Immunol; 2012 Apr; 56(4):245-53. PubMed ID: 22289120
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
Han S; Arvai AS; Clancy SB; Tainer JA
J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of cell surface receptor recognition by botulinum neurotoxin B.
Chai Q; Arndt JW; Dong M; Tepp WH; Johnson EA; Chapman ER; Stevens RC
Nature; 2006 Dec; 444(7122):1096-100. PubMed ID: 17167418
[TBL] [Abstract][Full Text] [Related]
16. A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1-A4.
Arndt JW; Jacobson MJ; Abola EE; Forsyth CM; Tepp WH; Marks JD; Johnson EA; Stevens RC
J Mol Biol; 2006 Sep; 362(4):733-42. PubMed ID: 16938310
[TBL] [Abstract][Full Text] [Related]
17. [Mechanisms of action of botulinum toxins and neurotoxins].
Poulain B; Lonchamp E; Jover E; Popoff MR; Molgó J
Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S73-6. PubMed ID: 19576489
[TBL] [Abstract][Full Text] [Related]
18. Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner.
Strotmeier J; Lee K; Völker AK; Mahrhold S; Zong Y; Zeiser J; Zhou J; Pich A; Bigalke H; Binz T; Rummel A; Jin R
Biochem J; 2010 Oct; 431(2):207-16. PubMed ID: 20704566
[TBL] [Abstract][Full Text] [Related]
19. Light chain of botulinum neurotoxin serotype A: structural resolution of a catalytic intermediate.
Fu Z; Chen S; Baldwin MR; Boldt GE; Crawford A; Janda KD; Barbieri JT; Kim JJ
Biochemistry; 2006 Jul; 45(29):8903-11. PubMed ID: 16846233
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of a novel botulinum neurotoxin.
Zhang S; Masuyer G; Zhang J; Shen Y; Lundin D; Henriksson L; Miyashita SI; Martínez-Carranza M; Dong M; Stenmark P
Nat Commun; 2017 Aug; 8():14130. PubMed ID: 28770820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
